Annual EBITDA
-$14.83 M
-$43.56 M-151.60%
December 31, 2023
Summary
- As of March 10, 2025, PRPH annual EBITDA is -$14.83 million, with the most recent change of -$43.56 million (-151.60%) on December 31, 2023.
- During the last 3 years, PRPH annual EBITDA has fallen by -$13.27 million (-849.84%).
- PRPH annual EBITDA is now -142.24% below its all-time high of $35.10 million, reached on December 31, 1997.
Performance
PRPH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$5.43 M
+$637.00 K+10.50%
September 30, 2024
Summary
- As of March 10, 2025, PRPH quarterly EBITDA is -$5.43 million, with the most recent change of +$637.00 thousand (+10.50%) on September 30, 2024.
- Over the past year, PRPH quarterly EBITDA has stayed the same.
- PRPH quarterly EBITDA is now -131.08% below its all-time high of $17.48 million, reached on March 31, 2022.
Performance
PRPH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$27.25 M
-$825.00 K-3.12%
September 30, 2024
Summary
- As of March 10, 2025, PRPH TTM EBITDA is -$27.25 million, with the most recent change of -$825.00 thousand (-3.12%) on September 30, 2024.
- Over the past year, PRPH TTM EBITDA has stayed the same.
- PRPH TTM EBITDA is now -162.01% below its all-time high of $43.95 million, reached on September 30, 2022.
Performance
PRPH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PRPH EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -151.6% | 0.0% | 0.0% |
3 y3 years | -849.8% | 0.0% | 0.0% |
5 y5 years | -1085.2% | -1029.1% | -2012.6% |
PRPH EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -151.6% | at low | -131.1% | +41.2% | -162.0% | at low |
5 y | 5-year | -151.6% | at low | -131.1% | +41.2% | -162.0% | at low |
alltime | all time | -142.2% | at low | -131.1% | +41.2% | -162.0% | at low |
ProPhase Labs EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$5.43 M(-10.5%) | -$27.25 M(+3.1%) |
Jun 2024 | - | -$6.07 M(-6.9%) | -$26.43 M(+12.4%) |
Mar 2024 | - | -$6.52 M(-29.4%) | -$23.50 M(+58.5%) |
Dec 2023 | -$14.83 M(-151.6%) | -$9.23 M(+100.5%) | -$14.83 M(+53.8%) |
Sep 2023 | - | -$4.61 M(+46.5%) | -$9.64 M(+469.3%) |
Jun 2023 | - | -$3.14 M(-245.8%) | -$1.69 M(-112.6%) |
Mar 2023 | - | $2.16 M(-153.3%) | $13.41 M(-53.3%) |
Dec 2022 | $28.73 M(+186.9%) | -$4.04 M(-221.1%) | $28.73 M(-34.6%) |
Sep 2022 | - | $3.34 M(-72.1%) | $43.95 M(+15.9%) |
Jun 2022 | - | $11.96 M(-31.5%) | $37.93 M(+48.4%) |
Mar 2022 | - | $17.48 M(+56.4%) | $25.56 M(+155.2%) |
Dec 2021 | $10.02 M(-741.6%) | $11.17 M(-517.5%) | $10.02 M(-707.4%) |
Sep 2021 | - | -$2.68 M(+555.9%) | -$1.65 M(-402.0%) |
Jun 2021 | - | -$408.00 K(-121.2%) | $546.00 K(-50.8%) |
Mar 2021 | - | $1.93 M(-490.5%) | $1.11 M(-171.7%) |
Dec 2020 | -$1.56 M(-42.4%) | -$494.00 K(+2.7%) | -$1.55 M(+19.9%) |
Sep 2020 | - | -$481.00 K(-410.3%) | -$1.29 M(+10.3%) |
Jun 2020 | - | $155.00 K(-121.3%) | -$1.17 M(-53.0%) |
Mar 2020 | - | -$727.00 K(+206.8%) | -$2.49 M(-8.0%) |
Dec 2019 | -$2.71 M(+116.5%) | -$237.00 K(-34.3%) | -$2.71 M(-2.6%) |
Sep 2019 | - | -$361.00 K(-69.1%) | -$2.78 M(-14.0%) |
Jun 2019 | - | -$1.17 M(+23.8%) | -$3.23 M(+44.6%) |
Mar 2019 | - | -$943.00 K(+204.2%) | -$2.24 M(+78.7%) |
Dec 2018 | -$1.25 M(-65.8%) | -$310.00 K(-62.0%) | -$1.25 M(-1.7%) |
Sep 2018 | - | -$815.00 K(+382.2%) | -$1.27 M(+1.5%) |
Jun 2018 | - | -$169.00 K(-502.4%) | -$1.25 M(-51.7%) |
Mar 2018 | - | $42.00 K(-112.7%) | -$2.60 M(-24.9%) |
Dec 2017 | -$3.65 M(+8.5%) | -$332.00 K(-58.3%) | -$3.46 M(-2.6%) |
Sep 2017 | - | -$796.00 K(-47.5%) | -$3.56 M(+4.9%) |
Jun 2017 | - | -$1.51 M(+84.5%) | -$3.39 M(+11.5%) |
Mar 2017 | - | -$821.00 K(+93.2%) | -$3.04 M(-9.7%) |
Dec 2016 | -$3.37 M(+97.0%) | -$425.00 K(-32.4%) | -$3.37 M(+31.0%) |
Sep 2016 | - | -$629.00 K(-46.1%) | -$2.57 M(+106.4%) |
Jun 2016 | - | -$1.17 M(+1.7%) | -$1.25 M(-20.2%) |
Mar 2016 | - | -$1.15 M(-408.3%) | -$1.56 M(-8.7%) |
Dec 2015 | -$1.71 M(-77.4%) | $372.00 K(-46.6%) | -$1.71 M(-72.7%) |
Sep 2015 | - | $696.00 K(-147.0%) | -$6.25 M(-4.1%) |
Jun 2015 | - | -$1.48 M(+14.4%) | -$6.52 M(-19.6%) |
Mar 2015 | - | -$1.30 M(-68.9%) | -$8.11 M(+7.4%) |
Dec 2014 | -$7.55 M(-1241.8%) | -$4.17 M(-1068.0%) | -$7.55 M(+178.7%) |
Sep 2014 | - | $431.00 K(-114.0%) | -$2.71 M(+47.0%) |
Jun 2014 | - | -$3.07 M(+315.7%) | -$1.84 M(+325.4%) |
Mar 2014 | - | -$738.00 K(-210.6%) | -$433.00 K(-165.6%) |
Dec 2013 | $661.00 K(-178.8%) | $667.00 K(-48.6%) | $660.00 K(+28.2%) |
Sep 2013 | - | $1.30 M(-178.2%) | $515.00 K(+43.9%) |
Jun 2013 | - | -$1.66 M(-567.3%) | $358.00 K(+141.9%) |
Mar 2013 | - | $355.00 K(-32.0%) | $148.00 K(-117.6%) |
Dec 2012 | -$839.00 K(-64.4%) | $522.00 K(-54.2%) | -$839.00 K(-73.0%) |
Sep 2012 | - | $1.14 M(-161.0%) | -$3.11 M(+2.3%) |
Jun 2012 | - | -$1.87 M(+195.7%) | -$3.04 M(+47.8%) |
Mar 2012 | - | -$632.00 K(-63.9%) | -$2.06 M(-12.6%) |
Dec 2011 | -$2.35 M(-27.1%) | -$1.75 M(-244.7%) | -$2.35 M(+39.3%) |
Sep 2011 | - | $1.21 M(-236.5%) | -$1.69 M(-9.4%) |
Jun 2011 | - | -$886.00 K(-4.5%) | -$1.87 M(-41.2%) |
Mar 2011 | - | -$928.00 K(-14.5%) | -$3.17 M(-1.7%) |
Dec 2010 | -$3.23 M | -$1.08 M(-205.0%) | -$3.23 M(+860.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2010 | - | $1.03 M(-147.1%) | -$336.00 K(+460.0%) |
Jun 2010 | - | -$2.19 M(+123.3%) | -$60.00 K(-97.4%) |
Mar 2010 | - | -$982.00 K(-154.4%) | -$2.34 M(-31.4%) |
Dec 2009 | -$3.41 M(-43.0%) | $1.81 M(+38.0%) | -$3.41 M(-52.7%) |
Sep 2009 | - | $1.31 M(-129.3%) | -$7.22 M(-6.4%) |
Jun 2009 | - | -$4.47 M(+117.9%) | -$7.71 M(+24.4%) |
Mar 2009 | - | -$2.05 M(+2.7%) | -$6.20 M(-7.8%) |
Dec 2008 | -$5.98 M(+285.6%) | -$2.00 M(-345.5%) | -$6.73 M(+165.9%) |
Sep 2008 | - | $814.00 K(-127.5%) | -$2.53 M(+15.8%) |
Jun 2008 | - | -$2.96 M(+14.8%) | -$2.19 M(-23.1%) |
Mar 2008 | - | -$2.58 M(-217.4%) | -$2.84 M(+34.7%) |
Dec 2007 | -$1.55 M(-1052.6%) | $2.20 M(+89.9%) | -$2.11 M(+4.3%) |
Sep 2007 | - | $1.16 M(-132.0%) | -$2.02 M(-11.7%) |
Jun 2007 | - | -$3.62 M(+95.7%) | -$2.29 M(+63.7%) |
Mar 2007 | - | -$1.85 M(-180.9%) | -$1.40 M(+20.3%) |
Dec 2006 | $162.90 K(-96.3%) | $2.29 M(+157.0%) | -$1.16 M(-12.4%) |
Sep 2006 | - | $889.70 K(-132.6%) | -$1.33 M(-291.3%) |
Jun 2006 | - | -$2.73 M(+69.1%) | $694.90 K(-55.5%) |
Mar 2006 | - | -$1.61 M(-176.0%) | $1.56 M(-47.6%) |
Dec 2005 | $4.38 M(+443.8%) | $2.12 M(-27.2%) | $2.98 M(+5.2%) |
Sep 2005 | - | $2.91 M(-256.6%) | $2.83 M(+333.1%) |
Jun 2005 | - | -$1.86 M(+854.5%) | $653.90 K(-59.2%) |
Mar 2005 | - | -$194.90 K(-109.9%) | $1.60 M(+60.8%) |
Dec 2004 | $806.10 K(-27.3%) | $1.97 M(+168.3%) | $996.40 K(-35.7%) |
Sep 2004 | - | $735.60 K(-180.6%) | $1.55 M(+66.8%) |
Jun 2004 | - | -$912.50 K(+14.0%) | $929.00 K(+22.7%) |
Mar 2004 | - | -$800.30 K(-131.7%) | $757.30 K(+19.2%) |
Dec 2003 | $1.11 M(-122.7%) | $2.53 M(+2093.2%) | $635.50 K(-117.2%) |
Sep 2003 | - | $115.20 K(-110.6%) | -$3.70 M(-10.8%) |
Jun 2003 | - | -$1.08 M(+17.6%) | -$4.14 M(-8.9%) |
Mar 2003 | - | -$922.10 K(-49.0%) | -$4.55 M(-15.8%) |
Dec 2002 | -$4.88 M(-574.3%) | -$1.81 M(+446.7%) | -$5.40 M(+1652.3%) |
Sep 2002 | - | -$330.70 K(-77.8%) | -$308.20 K(-4102.6%) |
Jun 2002 | - | -$1.49 M(-16.1%) | $7700.00(-101.2%) |
Mar 2002 | - | -$1.77 M(-154.0%) | -$649.70 K(-214.1%) |
Dec 2001 | $1.03 M(-119.2%) | $3.28 M(<-9900.0%) | $569.20 K(-123.2%) |
Sep 2001 | - | -$14.80 K(-99.3%) | -$2.45 M(-1.9%) |
Jun 2001 | - | -$2.15 M(+286.4%) | -$2.50 M(+15.5%) |
Mar 2001 | - | -$555.20 K(-309.2%) | -$2.16 M(-62.1%) |
Dec 2000 | -$5.35 M(-21.1%) | $265.40 K(-527.4%) | -$5.71 M(-23.4%) |
Sep 2000 | - | -$62.10 K(-96.6%) | -$7.45 M(-1.8%) |
Jun 2000 | - | -$1.81 M(-55.8%) | -$7.59 M(-2.9%) |
Mar 2000 | - | -$4.10 M(+176.9%) | -$7.82 M(+8.9%) |
Dec 1999 | -$6.78 M(-168.8%) | -$1.48 M(+640.0%) | -$7.18 M(+289.0%) |
Sep 1999 | - | -$200.00 K(-90.2%) | -$1.85 M(-164.7%) |
Jun 1999 | - | -$2.04 M(-41.2%) | $2.85 M(-36.4%) |
Mar 1999 | - | -$3.46 M(-189.9%) | $4.49 M(-53.5%) |
Dec 1998 | $9.85 M(-71.9%) | $3.85 M(-14.4%) | $9.65 M(-53.4%) |
Sep 1998 | - | $4.50 M(-1225.0%) | $20.70 M(-12.3%) |
Jun 1998 | - | -$400.00 K(-123.5%) | $23.60 M(-8.5%) |
Mar 1998 | - | $1.70 M(-88.6%) | $25.80 M(-26.3%) |
Dec 1997 | $35.10 M(-5114.3%) | $14.90 M(+101.4%) | $35.00 M(+74.1%) |
Sep 1997 | - | $7.40 M(+311.1%) | $20.10 M(+58.3%) |
Jun 1997 | - | $1.80 M(-83.5%) | $12.70 M(+16.5%) |
Mar 1997 | - | $10.90 M | $10.90 M |
Dec 1996 | -$700.00 K | - | - |
FAQ
- What is ProPhase Labs annual EBITDA?
- What is the all time high annual EBITDA for ProPhase Labs?
- What is ProPhase Labs annual EBITDA year-on-year change?
- What is ProPhase Labs quarterly EBITDA?
- What is the all time high quarterly EBITDA for ProPhase Labs?
- What is ProPhase Labs quarterly EBITDA year-on-year change?
- What is ProPhase Labs TTM EBITDA?
- What is the all time high TTM EBITDA for ProPhase Labs?
- What is ProPhase Labs TTM EBITDA year-on-year change?
What is ProPhase Labs annual EBITDA?
The current annual EBITDA of PRPH is -$14.83 M
What is the all time high annual EBITDA for ProPhase Labs?
ProPhase Labs all-time high annual EBITDA is $35.10 M
What is ProPhase Labs annual EBITDA year-on-year change?
Over the past year, PRPH annual EBITDA has changed by -$43.56 M (-151.60%)
What is ProPhase Labs quarterly EBITDA?
The current quarterly EBITDA of PRPH is -$5.43 M
What is the all time high quarterly EBITDA for ProPhase Labs?
ProPhase Labs all-time high quarterly EBITDA is $17.48 M
What is ProPhase Labs quarterly EBITDA year-on-year change?
Over the past year, PRPH quarterly EBITDA has changed by $0.00 (0.00%)
What is ProPhase Labs TTM EBITDA?
The current TTM EBITDA of PRPH is -$27.25 M
What is the all time high TTM EBITDA for ProPhase Labs?
ProPhase Labs all-time high TTM EBITDA is $43.95 M
What is ProPhase Labs TTM EBITDA year-on-year change?
Over the past year, PRPH TTM EBITDA has changed by $0.00 (0.00%)